Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial

IMPORTANCE: The consumption of broad-spectrum drugs has increased as a consequence of the spread of multidrug-resistant (MDR) Escherichia coli. Finding alternatives for these infections is critical, for which some neglected drugs may be an option. OBJECTIVE: To determine whether fosfomycin is noninf...

Descripción completa

Detalles Bibliográficos
Autores principales: Sojo-Dorado, Jesús, López-Hernández, Inmaculada, Rosso-Fernandez, Clara, Morales, Isabel M., Palacios-Baena, Zaira R., Hernández-Torres, Alicia, Merino de Lucas, Esperanza, Escolà-Vergé, Laura, Bereciartua, Elena, García-Vázquez, Elisa, Pintado, Vicente, Boix-Palop, Lucía, Natera-Kindelán, Clara, Sorlí, Luisa, Borrell, Nuria, Giner-Oncina, Livia, Amador-Prous, Concha, Shaw, Evelyn, Jover-Saenz, Alfredo, Molina, Jose, Martínez-Alvarez, Rosa M., Dueñas, Carlos J., Calvo-Montes, Jorge, Silva, Jose T., Cárdenes, Miguel A., Lecuona, María, Pomar, Virginia, Valiente de Santis, Lucía, Yagüe-Guirao, Genoveva, Lobo-Acosta, María Angeles, Merino-Bohórquez, Vicente, Pascual, Alvaro, Rodríguez-Baño, Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759008/
https://www.ncbi.nlm.nih.gov/pubmed/35024838
http://dx.doi.org/10.1001/jamanetworkopen.2021.37277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759008/
https://www.ncbi.nlm.nih.gov/pubmed/35024838
http://dx.doi.org/10.1001/jamanetworkopen.2021.37277

Ejemplares similares